The Iris and Junming Le Foundation was founded in 2006 to further health initiatives in research and patient care. The Le Foundation believes that providing support to medical professionals engaged in research guarantees the sustained pursuit of innovation that leads to wide-ranging improvements in health. Furthermore, involving future generations and instilling a passion for medical discovery secures the development of new researchers armed to solve the problems of tomorrow.
Funding for The Le Foundation is mainly provided by a royalty stream from the invention of Remicade in 1989 by Dr. Junming Le, Adjunct Associate Professor of Microbiology, New York University School of Medicine. Remicade is a new class of medicine effectively treating a number of autoimmune diseases including rheumatoid arthritis, psoriasis, Crohn's disease, and is currently manufactured and marketed by Johnson & Johnson and Merck. Additionally, The Le Foundation actively seeks various investment opportunities, such as real estate and acquisitions, in order to enhance its diversified financial portfolio. In addition, The Le Foundation supports various arts and humanitarian initiatives.
The Iris and Junming Le Foundation has been involved with the following programs:
Orthopaedic Senior Resident Research Award at Hospital for Joint Diseases
An endowment was created to annually award a resident in the Orthopaedic Department who exhibits exemplary research commitment and skill.
Donation to International Health Program at NYU School of Medicine
Provided financial assistance for students to travel abroad and participate in clinical or basic research, public health initiatives, or clinical education programs.
Curriculum for the C21 Initiative of NYU School of Medicine
The Le Foundation supported Online Database Literature as part of the Curriculum for the 21st Century initiative.
Le Foundation Neuroimaging Research Grants at Mt. Sinai School of Medicine
The Le Foundation provided a two-year grant for neuroimaging research conducted by young scientists at the Department of Psychiatry.
Le Foundation Fellowship Grant for Translational Oncology Research at Memorial Sloan-Kettering Cancer Center
A two-year grant was provided to fund research by HOPP program fellows.
Purchase of Boca Raton Regional Hospital ScanScope
The Le Foundation purchased a cutting-edge ScanScope that will allow cooperations between doctors in virtual diagnosis on pathological slides and sharing medical information.
Le Foundation Pilot Grants Program at Rockefeller University
The Le Foundation funded about a dozen 1-year grants of beginning-stage studies in translational science that might lead to improvements in human health.
Purchase of Boca Raton Regional Hospital Endoscopic Ultrasound
The Le Foundation purchased a cutting-edge Endoscopic Ultrasound that will expand the capacity of the Lynn Cancer Institute to provide ultrasound, biopsy, and therapeutic interventions with hepatobiliary disease.
Purchase of New York Hospital Queens Digital Portable X Ray Machine
The Le Foundation purchased an innovative Portable Imaging machine that allows digital X Rays to be taken bedside and to be viewed immediately on the console for physicians to review.
Support for New York Public Radio Medical Science and Research Reporting
The Le Foundation provided financial support to the radio station's new health project initiative.
Dr. Junming Le, Chairman and Director
Iris Le (Sai Hong Yan), Director
Daniella Ann Loh, Director
Roslyn Ceresne, Financial Analyst for Real Estate Market
Uri Weg, Manager